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SUMMARY 
 Monascus purpureus, used as a food additive, coloring and flavoring agent in 
foods and beverages in ancient China. Production of secondary metabolites like 
polyketides, statins, sterol and fatty acids during solid-state and shake flask culture by 
M. purpureus and its mutants through different fermentation conditions were studied. 
Mutant CFR 410-11 over produced polyketide pigments (1148 OD Units) compared to 
M. purpureus MTCC 410 (604 OD Units). The mutant CFR 410-22 showed low 
quantity of polyketide pigments (473 OD Units) compared to MTCC 410 in solid-state 
cultures.  
A comparative study made by TLC and HPLC revealed that statin produced by 
M. purpureus and its mutants were similar to the commercial statin with Rf value and 
retention time. Solid-state cultures produces highest amount of statin compared to 
shake flask cultures. More sterols are produced in shake flask cultures compared to 
solid-state. Significant amount of fatty acids production in solid-state than in shake 
flask cultures were confirmed by GC. 
 
Among the metabolites of M. purpureus, lovastatin (Monacolin K) potent 
inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA) is found to be 
very important and have been proven to be cholesterol lowering drug. Cultural 
condition has a significant influence on the yield of statin. Maltose (5.09 mg/g) and 
peptone (5.53 mg/g) as carbon and nitrogen source with pH 5.0 (5.79 mg/g) and 28° C 
(5.99 mg/g) is the optimum condition for statin production. 
 
L-asparaginase (0.103 IU) and L-glutaminase (0.139 IU) activity was 
comparatively more in CFR 410-11 than MTCC 410 and CFR 410-22. The mutant 
CFR 410-11 secreted more red pigment cultured on rice (2.248 OD Units) and in 
broth (0.841 OD Units). Significant difference in amidase activities in MTCC 410 and 
its mutant CFR 410-11 and CFR 410-22 revealed the importance of these enzymes in 
pigment production. 
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Safety of RMR was assessed by conducting acute and sub-chronic 
toxicological studies on both sexes of albino rats. Feeding acute doses of RMR did 
not cause any symptoms of toxicity or mortality. Similarly, dietary feeding of RMR 
did not produce any significant changes in food intake or gain in body weight of the 
experimental rats compared to control rats. No significant differences in the relative 
weight of vital organs, hematological parameters, macroscopic and microscopic 
changes in vital organs and serum clinical enzyme levels between the experimental 
and control groups. 
RMR containing lovastatin at a concentration of 11.51g/ kg reduced total 
cholesterol (TC), triglyceride (TG), lipoprotein cholesterol (LDL) in high fat diet 
(HFD) fed Wistar rats. There was no significant difference with regard to the food 
intake, gain in body weight and organ weights of rats in different dietary groups. 
RMR significantly lowered serum and hepatic cholesterol and triacylglycerol levels. 
LDL-C levels decreased by 66.28 and 70.12%, while HDL-C increased by 44.45 and 
34.58% in serum of 16% RMR fed groups for 7 and 14 weeks, respectively. The 
atherogenic indices (LDL-C/HDL-C and TC/HDL-C) of 16% RMR for 14 weeks 
were reduced by 77.80 and 61.05%, respectively. RMR fed groups resulted in 22 to 
54% inhibition of HMG-CoA reductase activity in liver. Further, the hypolipidemic 
effect of RMR was comparable to therapeutic drug lovastatin. In addition, histological 
examinations of liver of hyperlipidemic rats showed decreased lipid accumulation in 
red mould rice powder fed rats. 
RMR effectively scavenged 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radicals 
(IC50=100µg/ml). The consumption of RMR with HFD showed increased enzyme 
activity (glutathione reductase, glutathione peroxidase, superoxide dismutase and 
catalase) and increased levels of non-enzymic (total thiols, glutathione and ascorbic 
acid) antioxidants in rats. Lipid peroxidation was significantly inhibited in rats 
(46µmol/dl) fed on RMR compared to rats fed on HFD only (99µmol/dl). The 
treatment of 16% RMR is equivalent to 80mg of lovastatin. This study has confirmed 
that, consumption of RMR can induce antioxidant enzymes and molecules to 
scavenge the reactive oxygen species (ROS) released due to oxidative stress in rats 
fed on HFD. 
